Acasti Pharma Offers Update On TRILOGY 1, 2 Phase 3 Trials Of CaPre: Probe Underway Into Unexpected, Inconsistent Findings That May Have Negatively Impacted Results Of TRILOGY 1

Benzinga · 02/10/2020 12:07